Loes Kistemaker (Groningen, Netherlands), Adam Barczyk (Katowice, Poland), Leif Bjermer (Lund, Sweden)
Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Emanuel Citgez (Wierden, Netherlands), Emanuel Citgez, Job van der Palen, Paul van der Valk, Kirsten Koehorst-ter Huurne, Kris Movig, Marjolein Brusse-Keizer
|   |
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Peter M. A. Calverley (Liverpool, United Kingdom), Peter M.A. Calverley, Emiel F.M. Wouters, Helen Finnigan, Kay Tetzlaff, Helgo Magnussen
| |
Experience of application the selective phosphodiesterase-4 inhibitor roflumilast in the patient with COPD and the metabolic syndrome
Elena Blinova (Chelyabinsk, Chelyabinsk Oblast, Russian Federation), Elena Blinova, Galina Ignatova, Maria Belsner
| |
Glaucoma risk due to antimuscarinics, not a class effect: A systematic review
Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Carlos Andrés Celis Preciado, Horacio Giraldo, Dario Londoño, Ingrid Rodriguez
| |
Direct cost analysis of COPD patients: A 1 year follow-up study
Suleyman Savas Hacievliyagil (Malatya, Turkey), Ünal Akel, Süleyman Savas Hacievliyagil, Zeynep Ayfer Aytemur, Saim Yologlu, Saltuk Bugra Kaya, Nazan Akel
| |
The use of a new intra-pulmonary percussive ventilation (IPPV) device to aid lung volume recruitment (LVR) and secretion clearance in a patient with C1 spinal cord injury (SCI)
Liam Campbell (Newcastle Upon Tyne, United Kingdom), Liam Campbell, Alison Armstrong
| |
The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment
Iryna Savelikhina (Ivano-Frankivsk, Ukraine), Iryna Savelikhina, Oleksandr Varunkiv, Mykola Ostrovskyy, Mariana Kulynych-Miskiv, Kseniia Ostrovska
| |
Characterization of readmissions in patients hospitalized with COPD exacerbation
Andres Gimenez Velando (Madrid, Spain), Andres Gimenez Velando, Elena Cabezas Pastor, Reyes Calzado López, Herminia Ortiz Mayoral, Alba Naya Prieto, Pilar Carballosa De Miguel, Germán Peces-Barba Romero, Felipe Villar Álvarez
| |
Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD
Antoine Poskin (Vilvoorde, Belgium), Walter Vincken, Antoine Poskin, Sandra Gurdain, Jan Van Schoor, Stefaan Vancayzeele, Paul Van den Brande
| |
Bronchodilator use in Latin America primary care: The PUMA study
Maria Montes De Oca (Caracas, Venezuela), Maria Montes De Oca, Maria Victorina Lopez Varela, Jose Jardim, Roberto Stirvulov, Filip Surmont
| |
Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD)
Maurizio Moretti (Modena, Italy), Maurizio Moretti
| |
Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients
Mathieu Molimard (Bordeaux, France), Mathieu Molimard, C. Raherison, S. Lamarque, S. Lignot-Maleyran, A. Balestra, A. Chartier, R. Lassalle, C. Droz-Perroteau, P.O. Girodet
| |
Medication adherence in high exacerbation risk groups of COPD
Esra Uzaslan (Bursa, Turkey), Esra Uzaslan, Nilüfer Aylin Acet Öztürk, Asli Görek Dilektasli, Ezgi Demirdögen Çetinoglu, Funda Coskun, Ahmet Ursavas, Mehmet Karadag
| |
Effectiveness of glycopyrronium bromide in the treatment of small airways dysfunction
Albino Petrone (Cosenza, Italy), Albino Petrone, Filippo Fimognari, Michela Quartieri, Giacomo Bruni
| |
Treatment of combined pulmonary fibrosis and emphysema
Jee Youn Oh (Seoul, Republic of Korea), Jee Youn Oh, Juwhan Choi, Sangmi Chung, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang
| |
Optimizing patient experience of nebulizer treatments
Ross Hatley (Chichester, United Kingdom), Ross Hatley, Louise Rowe, Ian Rabbetts, Filippo Quadrelli
| |
Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Daniel Dusser (Paris, France), Daniel Dusser, Peter M.A. Calverley, Robert A. Wise, Achim Mueller, Norbert Metzdorf, Antonio Anzueto
| |
Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study
Samy Suissa (Montreal, Canada), Samy Suissa, Sophie Dell’Aniello, Pierre Ernst
| |
The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients
Hassan Ghobadi-Marallu (Ardabil, Islamic Republic of Iran), Hassan Ghobadi-Marallu, Somaieh Matin, Ali Nemati, Abbas Naghizadeh Baghi
| |